Deep 6 uses AI to, in its own words, “find more patients in minutes, not months.” The patients in this sense are participants in clinical trials — a critical part of the research process in developing new medicine. Certainly one of the challenging issues that were faced during the quest for a COVID-19 vaccine was finding a community of appropriate candidates. Deep 6 finds these kinds of communities by using an AI-powered system to scan through medical records, with the ability to understand patterns in human health.
The company has raised over $17.6 million in funding from investors such as Point72 Ventures and Summation Health Ventures. The company has not announced any plans for an initial public offering (IPO) as of September 2021. However, some sources speculate that the earliest Deep 6 AI could go public is in 2024 . Deep 6 AI is an artificial intelligence company that provides real-time information and alerts to its clients across various industries and sectors.